New Study Reveals Cost-Effective Lumbar Facet Arthroplasty For Degenerative Spondylolisthesis And Stenosis
NORWALK, Conn., Feb. 8, 2024 /PRNewswire-PRWeb/ -- In a significant development, Premia Spine, a leading medical device company, has unveiled the results of a groundbreaking study published in The Spine Journal, reaffirming the cost-effectiveness and superiority of their Total Posterior Spine (TOPS™) System. This study, titled "A Prospective Study of Lumbar Facet Arthroplasty in the Treatment of Degenerative Spondylolisthesis and Stenosis," presents a comprehensive evaluation based on an updated FDA investigational device exemption (IDE) dataset. Read Full Study Here: The Spine Journal
- This study, titled " A Prospective Study of Lumbar Facet Arthroplasty in the Treatment of Degenerative Spondylolisthesis and Stenosis ," presents a comprehensive evaluation based on an updated FDA investigational device exemption (IDE) dataset.
- Read Full Study Here: The Spine Journal
This updated analysis solidifies the TOPS™ System as a highly cost-effective and dominant surgical option for patients with lumbar stenosis and degenerative spondylolisthesis, offering significant benefits to both healthcare systems and patients alike. - Conducted as a multicenter, FDA IDE, randomized control trial (RCT) with 305 enrolled subjects, the study yielded significant insights.
- Overall, this updated analysis solidifies the TOPS™ System as a highly cost-effective and dominant surgical option for patients with lumbar stenosis and degenerative spondylolisthesis, offering significant benefits to both healthcare systems and patients alike.